Evidence map›Paper›PMID 42157309›Full record

ArticleJournal of cardiothoracic surgery2026

SXRNSCLC-PRSP software to predict prognostic risk and survival in patients with resected T

Yunkui Zhang, Xuesong Wu, Bin Yang, Rongsheng Zhang, Bin Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yunkui ZhangDepartment of Thoracic Surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, No. 3 Zhigongxin Street, Taiyuan, 030013, Shanxi, China.
Xuesong WuDepartment of Head and Neck Surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, No. 3 Zhigongxin Street, Taiyuan, 030013, Shanxi, China.
Bin YangDepartment of Thoracic Surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, No. 3 Zhigongxin Street, Taiyuan, 030013, Shanxi, China.
Rongsheng ZhangDepartment of Thoracic Surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, No. 3 Zhigongxin Street, Taiyuan, 030013, Shanxi, China.
Bin WangDepartment of Thoracic Surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, No. 3 Zhigongxin Street, Taiyuan, 030013, Shanxi, China. 2561262877@qq.com.

Funding

Shanxi Provincial Health Commission Talent Special Research Project Funding 2020059
6 · The paper itself

Abstract

objectiveTo develop SXRNSCLC-PRSP software which can predict the prognostic risk and survival of resected T

methodsPatients with NSCLC whose tumor stage is T

resultsUsing a Cox proportional hazard regression model, we determined the independent prognostic factors and obtained a prognostic index (PI) eq. PI = [Formula: see text] = -0.392X

conclusionsAfter prognostic factor analysis, prognostic risk grouping and corresponding survival assessment, we developed a novel software program and established the Risk Assessment System (RAS). It is practical and convenient for clinicians to evaluate the prognostic risk and corresponding survival of patients with resected T

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsSoftwareAgedChinaFemaleHumansMaleMiddle AgedNeoplasm StagingPrognosisRisk AssessmentSurvival RatePrognostic indexPrognostic risk predictionResected non-small cell lung cancerRisk assessment systemSoftwareSurvival prediction

Identifiers

PMID42157309
PMCPMC13371126

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.